Capricor Therapeutics - 23 Year Stock Price History | CAPR
Historical daily share price chart and data for Capricor Therapeutics since 2002 adjusted for splits and dividends. The latest closing stock price for Capricor Therapeutics as of July 03, 2025 is 10.25.
- The all-time high Capricor Therapeutics stock closing price was 8000.00 on December 17, 2002.
- The Capricor Therapeutics 52-week high stock price is 23.40, which is 128.3% above the current share price.
- The Capricor Therapeutics 52-week low stock price is 3.52, which is 65.7% below the current share price.
- The average Capricor Therapeutics stock price for the last 52 weeks is 11.79.
| Capricor Therapeutics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 12.1416 | 14.9600 | 15.9500 | 6.3400 | 10.2500 | -25.72% |
| 2024 | 8.2706 | 5.1200 | 21.9900 | 3.5600 | 13.8000 | 182.21% |
| 2023 | 4.3936 | 3.8500 | 7.8500 | 2.7100 | 4.8900 | 26.68% |
| 2022 | 4.3533 | 3.1800 | 6.5500 | 2.8300 | 3.8600 | 31.74% |
| 2021 | 4.4994 | 3.7400 | 7.9300 | 2.8900 | 2.9300 | -14.58% |
| 2020 | 3.9987 | 1.2300 | 9.8100 | 0.9400 | 3.4300 | 167.97% |
| 2019 | 3.6947 | 4.9500 | 6.7990 | 1.0400 | 1.2800 | -68.78% |
| 2018 | 12.6679 | 15.7000 | 20.9000 | 3.2000 | 4.1000 | -74.05% |
| 2017 | 19.8844 | 25.5000 | 34.5000 | 6.3400 | 15.8000 | -40.60% |
| 2016 | 31.8688 | 29.4000 | 47.5000 | 20.1000 | 26.6000 | -13.46% |
| 2015 | 52.2585 | 37.5000 | 102.5000 | 26.5000 | 30.7360 | -18.04% |
| 2014 | 59.9506 | 34.0000 | 155.0000 | 34.0000 | 37.5000 | 15.38% |
| 2013 | 37.0096 | 20.0000 | 92.5000 | 14.5000 | 32.5000 | 33.47% |
| 2012 | 119.4879 | 272.5000 | 290.0000 | 13.0000 | 24.3500 | -91.06% |
| 2011 | 317.3097 | 290.0000 | 439.7000 | 240.0000 | 272.5000 | -12.10% |
| 2010 | 352.5188 | 590.0000 | 629.9500 | 150.0000 | 310.0000 | -48.76% |
| 2009 | 593.0480 | 400.0000 | 1080.0000 | 165.0500 | 605.0000 | 42.35% |
| 2008 | 1943.6163 | 2750.0000 | 2750.0000 | 210.0000 | 425.0000 | -84.55% |
| 2007 | 2259.5750 | 1750.0000 | 3250.0000 | 450.0000 | 2750.0000 | 37.50% |
| 2006 | 2635.0000 | 1750.0000 | 3750.0000 | 1750.0000 | 2000.0000 | -38.46% |
| 2005 | 2809.0909 | 2550.0000 | 3250.0000 | 2500.0000 | 3250.0000 | 0.00% |
| 2004 | 3778.5714 | 3750.0000 | 6250.0000 | 2550.0000 | 3250.0000 | 27.45% |
| 2003 | 5977.2321 | 7000.0000 | 7500.0000 | 2550.0000 | 2550.0000 | -63.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.468B | $0.022B |
| Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |